Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses

Key Points

• This research aims to explore the effects of hypolipidemic treatment on the development of Alzheimer's disease and dementia progression.
• Cohort study design linking genetic and neuropathological analyses
• Evaluation of hypolipidemic treatment effects on cognitive functionality
• Assessment of dementia progression based on various etiologies
• Hypolipidemics were associated with a reduced rate of Alzheimer's disease development
• Dementia progression was significantly slowed in individuals receiving hypolipidemic treatment
• Cognitive dysfunction was delayed regardless of the underlying cause